Bioasis Announces Filing of Its First Quarter Financial Statements and MD&A
The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders.
- The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders.
- The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
- Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement.
- All forward-looking statements and information made herein are based on our current expectations and we undertake no obligation to revise or update such forward-looking statements and information to reflect subsequent events or circumstances, except as required by law.